Farmamondo and AQTIS Medical, a company dedicated to innovative products in the esthetic field, signed an exclusive agreement to approve, market and sale the proprietary esthetic product line ELLANSE® in the markets of Switzerland, Taiwan and Malaysia.
About AQTIS Medical: AQTIS Medical (Netherlands) is specialized in the research, development, manufacturing and commercialization of innovative injectable medical devices, specifically designed for minimal invasive therapies within medical aesthetics and other therapeutic areas. The focus is on medical devices that are used by physicians to enhance patients’ quality of life and well-being.
About Farmamondo: Farmamondo is a Swiss-based pharmaceutical company with a focus on providing patient access to their unmet medical need via Early-access, Named-patient and Compassionate-use programs. Our global footprint includes commercial operations in more than 50 markets, headquartered from Switzerland with regional hubs in Europe, Asia and Latin America.